Page 6 - SpringNews2022
P. 6

A Banner Year for Guidelines!

                                                                Some of the new topics being covered in upcoming guidelines
                      Bobby Shayegan                            include:
                      Chair, Guidelines Committee               •   Nocturia
                      Hamilton, ON                              •   Testicular germ cell cancer management
                                                                •   Postoperative surveillance of upper tract urothelial cancer
                                                                •   Azoospermic males
                                                                •   Stress urinary incontinence in women
        2021 was a banner year for the CUA Guidelines Committee: a   •   Incidentally detected adrenal mass
        record 10 guidelines/best practice reports/consensus statements   •   Interstitial cystitis/bladder pain syndrome
        were either newly developed or updated! And 2022 is looking   •   Penile cancer
        even more productive. At press time, we have published a new
        guideline on small renal masses and an update of the 2017   •   Screening for Lynch syndrome
        prostate cancer screening guideline.                    Additionally, the Guidelines Committee recently welcomed
        Additional updates on the following topics are forthcoming:  a new member: Bimal Bhindi. With Dr. Bhindi’s appointment,
        •   Medical management of kidney stones                 we have ensured that the committee’s expertise spans most
                                                                major urological subspecialties — oncology (prostate, kidney,
        •   Vasectomy                                           bladder), reconstruction, endourology, functional urology,
        •   Male lower urinary tract symptoms/benign prostatic           pediatrics, and community practice.
           hyperplasia                                          Finally, we continue to offer value-added features associated
        •   Metastatic castration-naive and castration-sensitive           with guidelines. Visit cua.org to view both English and French
           prostate cancer                                      versions of the guidelines, summary slide presentations, and the
        •   Castration-resistant prostate cancer                opportunity to claim Section 3 MOC credits (via UROpedia).
        •   ADT: Adverse events and management strategies
                                                                Our goal is to ensure that guidelines are constructed for the
                                                                optimal use of CUA members and to benefit the patients
                                                                we care for. If you have any comments or suggestions,
                                                                please contact the CUA Guidelines Manager at
                                                                adriana.modica@cua.org.




                                                     Join the International

                                                     Urology Community



                                                     for the 42nd Congress of the
                                                     Société Internationale d’Urologie

                                                     Featuring the
                                                     7th SIU Global Nurses’ Educational Symposium



                                                                          Abstract Deadline: April 17



                                                                     In conjunction with the



                                                                     Reviewed and endorsed by the
                                                                     Canadian Urological Association
                                                                     (December 2021)



                                                         siu-urology.org       #SIU2022       #B2BGUCancerTriad


        6
   1   2   3   4   5   6   7   8   9   10   11